AHMEDABAD, India & VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical SA (Paris:AMPLI): Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited (“Zydus ...

Zydus Lifesciences and Amplitude Surgical SA confirm that Amplitude has conducted the mandatory information and consultation process with the works council of Amplitude SAS. Consequently, Zydus has ...

Brokerage firms remain divided on Zydus Lifesciences Ltd as the company announced to acquire Amplitude Surgical for €257 million (Rs 2,500 crore). The Ahmedabad-based drug maker has entered into ...

NEW DELHI: Zydus Lifesciences on Tuesday said it has entered into negotiations to acquire a majority stake in France-based Amplitude Surgical, a medtech firm, for 256.8 million euro (around Rs ...

Zydus Lifesciences Limited announces the execution of undertakings from 7 shareholders to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company's capital and voting rights by ...

USFDA's final approval is available for Zydus Lifesciences and group companies ... which Zydus plans to acquire the equity shares of Amplitude Surgical SA.

It is indicated for the treatment of relapsing forms of Multiple Sclerosis, to include clinically isolated syndrome, ...

The United States is Zydus Lifesciences's biggest market, accounting for 47% of total revenue, followed by India. "In Amplitude Surgical, we see several medium-term and long-term growth opportunities ...

Amplitude Surgical SA (Paris:AMPLI): Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited (“Zydus”) and Amplitude Surgical SA (Paris:AMPLI) (“Amplitude”) confirm ...

AHMEDABAD, India & VALENCE, France, April 25, 2025--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical SA (Paris:AMPLI): Following the joint announcement of March 11, 2025, Zydus Lifesciences ...